No. | Sex | Age-ranges | HNSCC | ESCC | This study | Geurts et al., 2005 [16] | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Site | Stagea | Site | Stagea | %Discordant LOH | %Concordant LOH | Ratio | Conclusion | Discordant LOHb | Concordant LOH | All discordant LOH | Conclusion | |||
1 | M | 56–60 | oropharynx | T3 N0 M0 | middle | T2 N0 M0 | 95.45 | 4.55 | 17.2 | SFT/SPM | 0 | 1 | 5 | SPM |
2 | M | 61–65 | oropharynx | T1 N0 M0 | middle | T2 N1 M0 | 56.25 | 43.75 | 1.3 | Undetermined | 0 | 0 | 0 | ? |
3 | M | 61–65 | oropharynx | T2 N1 M0 | middle | T2 N1 M0 | 100 | 0 | 100 | SPM | 2 | 0 | 2 | SPM |
4 | M | 36–40 | larynx | T3 N3 M0 | middle | T1 N0 M0 | 95.45 | 4.55 | 17.2 | SFT/SPM | 5 | 0 | 5 | SPM |
5 | M | 51–55 | larynx | T1 N0 M0 | middle | T2 N1 M0 | 92.5 | 7.5 | 10.9 | SFT/SPM | 4 | 2 | 12 | SPM |
6 | M | 61–65 | larynx | T1 N0 M0 | middle | T2 N0 M0 | 83.33 | 16.67 | 4.7 | SFT/SPM | 1 | 2 | 4 | Metas? |
7 | M | 61–65 | larynx | T3 N2 M0 | middle | T2 N1 M0 | 100 | 0 | 100 | SPM | 3 | 0 | 10 | SPM |
8 | M | 76–80 | larynx | T3 N0 M0 | middle | T2 N0 M0 | 93.75 | 6.25 | 12.9 | SFT/SPM | 4 | 1 | 7 | SPM |
9 | M | 41–45 | hypopharynx | T3 N2 M0 | middle | T3 N1 M0 | 75 | 25 | 2.9 | SFT/SPM | 3 | 2 | 6 | SPM |
10 | M | 41–45 | hypopharynx | T4 N2 M0 | middle | T3 N1 M0 | 92.59 | 7.41 | 11 | SFT/SPM | 8 | 0 | 12 | SPM |
11 | M | 51–55 | hypopharynx | T2 N2 M0 | middle | T2 N1 M0 | 100 | 0 | 100 | SPM | 0 | 0 | 0 | ? |
12 | M | 56–60 | hypopharynx | T2 N0 M0 | middle | T2 N0 M0 | 87.1 | 12.9 | 6.3 | SFT/SPM | 8 | 0 | 10 | SPM |
13 | M | 61–65 | hypopharynx | T3 N0 M0 | middle | T3 N2 M0 | 81.82 | 18.18 | 4.3 | SFT/SPM | 4 | 1 | 12 | SPM |
14 | F | 66–70 | hypopharynx | T3 N2 M0 | middle | T2 N0 M0 | 98.25 | 1.75 | 35.7 | SFT/SPM | 5 | 1 | 9 | SPM |
15 | M | 81–85 | hypopharynx | T1 N3 M0 | middle | T2 N1 M0 | 93.75 | 6.25 | 12.9 | SFT/SPM | 0 | 0 | 1 | ? |
16 | M | 71–75 | oropharynx | T3 N1 M0 | lower | T2 N0 M0 | 94.87 | 5.13 | 15.5 | SFT/SPM | 4 | 0 | 4 | SPM |
17 | M | 46–50 | larynx | T1 N0 M0 | lower | T2 N1 M0 | 100 | 0 | 100 | SPM | 7 | 0 | 8 | SPM |
18 | M | 71–75 | larynx | T2 N1 M0 | lower | T2 N0 M0 | 87.5 | 12.5 | 6.5 | SFT/SPM | 9 | 2 | 11 | SPM |
19 | M | 41–45 | hypopharynx | T4 N2 M0 | lower | T3 N2 M0 | 100 | 0 | 100 | SPM | 0 | 0 | 2 | SPM? |
20 | M | 46–50 | hypopharynx | T3 N2 M0 | lower | T2 N0 M0 | 95 | 5 | 15.8 | SFT/SPM | 4 | 0 | 7 | SPM |
21 | M | 51–55 | hypopharynx | T2 N0 M0 | lower | T2 N2 M0 | 100 | 0 | 100 | SPM | 1 | 0 | 3 | SPM? |